DMF filings hit all-time high in Q3 2024; China tops list with 58% increase in Type II submissions

Data Compilation
#PharmaFlow

Pipeline Prospector Sept 2024: BMS wins landmark FDA approval for schizophrenia med; Sanofi’s Dupixent okayed for COPD

Stock Recap
#PipelineProspector

LIDODERM

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

48 API Suppliers, 18 USDMF, 5 CEP/COS, 5 JDMF, 10 EU WC, 8 KDMF, 24 NDC API, 30 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

32 Drugs in Development

32 Drugs in Development

INTERMEDIATES

1 Intermediates Suppliers

1 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

263 FDF Dossiers, 51 FDA Orange Book, 121 Europe, 19 Canada, 3 Australia, 14 South Africa, 55 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - 2.5%;2.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, PATCH;TOPICAL - 5%, PATCH;TOPICAL - 70MG;70MG, CREAM;TOPICAL - 7%;7%

RELATED EXCIPIENT COMPANIES

1 Minakem, 1 Evonik, 3 Rochem International Inc, 12 SPI Pharma, 3 Seqens, 18 DKSH, 2 Jai Radhe Sales, 1 PMC Isochem, 2 Pharm-RX Chemical, 9 Boai NKY Pharmaceuticals Ltd, 9 Gangwal Healthcare, 2 Kewpie Corporation, 24 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 ACG Worldwide, 17 Actylis, 3 Aeon Procare, 2 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 52 BASF, 1 Bioplus Life Sciences, 1 BioSpectra, 3 Clariant, 13 Corel Pharma Chem, 1 DFE Pharma, 3 Doshion Polyscience, 5 Finar, 18 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 2 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 11 Kerry, 1 Kima Chemical, 3 Lonza Capsugel, 8 Lubrizol Life Science Health, 17 Microlex e.U, 4 Nanjing Bold Chemical, 3 Nippon Fine Chemical, 2 Nomisma Healthcare, 4 Novo Excipients, 2 Pharmatrans-Sanaq, 7 Pluviaendo, 3 Prachin Chemical, 1 Qualicaps, 19 Roquette, 16 Seppic, 2 Shandong Focus Biotechnology Co., Ltd, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 4 Sigachi Industries, 1 The Dow Chemical Company, 3 Ulanqab Kema New Material, 2 Valens Pharmachem, 2 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

85 Topical, 73 Solubilizers, 61 Fillers, Diluents & Binders, 50 Thickeners and Stabilizers, 43 Parenteral, 37 Direct Compression, 34 Emulsifying Agents, 33 Coating Systems & Additives, 31 Disintegrants & Superdisintegrants, 29 Film Formers & Plasticizers, 25 Lubricants & Glidants, 25 Granulation, 22 Surfactant & Foaming Agents, 20 Co-Processed Excipients, 19 Controlled & Modified Release, 18 Taste Masking, 12 Rheology Modifiers, 11 Chewable & Orodispersible Aids, 8 Empty Capsules, 7 API Stability Enhancers, 2 Coloring Agents, 1 Dry Powder Inhalation, 1 Soft Gelatin

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 103 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

5 US Medicaid Prescriptions, 78 Finished Drug Prices, 1 Annual Reports

MARKET PLACE

30 APIs, 23 FDF Dossiers

PATENTS & EXCLUSIVITIES

11 US Patents, 1 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 1 USP, 15 Others

$ Xls download

Filters

Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	MF Registration No.	Classification	Initial Date of Reg.	Latest Date of Reg.	Registrant's Address
26/09/2024	Moehs Iberica	Spain	MOEHS IBERICA S. L.	217MF11155	Lidocaine	2005-12-12	2021-03-05	Cesar Martinell i Brunet 12A, Poligono Rubi Sur, Rubi (Barcelona), Spain
26/09/2024	Cambrex Corporation	U.S.A	Cambrex Karlskoga AB	222MF10045	Lidocaine	2010-02-09	2018-04-09	SE-691 85 Karlskoga, SWEDEN

LIDODERM

LIDODERM

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

48 API Suppliers

18 USDMF

5 CEP/COS

5 JDMF

10 EU WC

8 KDMF

24 NDC API

30 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

32 Drugs in Development

INTERMEDIATES

1 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

263 FDF Dossiers

51 FDA Orange Book

121 Europe

19 Canada

3 Australia

14 South Africa

55 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - 2.5%;2.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

PATCH;TOPICAL - 5%

PATCH;TOPICAL - 70MG;70MG

CREAM;TOPICAL - 7%;7%

RELATED EXCIPIENT COMPANIES

1 Minakem

1 Evonik

3 Rochem International Inc

12 SPI Pharma

3 Seqens

18 DKSH

2 Jai Radhe Sales

1 PMC Isochem

2 Pharm-RX Chemical

9 Boai NKY Pharmaceuticals Ltd

9 Gangwal Healthcare

2 Kewpie Corporation

24 Nanjing Well Pharmaceutical

2 Pfanstiehl

4 ACG Worldwide

17 Actylis

3 Aeon Procare

2 Alcedo Pharmachem

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

52 BASF

1 Bioplus Life Sciences

1 BioSpectra

3 Clariant

13 Corel Pharma Chem

1 DFE Pharma

3 Doshion Polyscience

5 Finar

18 Gangwal Chemicals

1 Huzhou Sunflower Pharmaceutical

2 Ideal Cures Pvt Ltd

3 Ingredion Pharma Solutions

11 Kerry

1 Kima Chemical

3 Lonza Capsugel

8 Lubrizol Life Science Health

17 Microlex e.U

4 Nanjing Bold Chemical

3 Nippon Fine Chemical

2 Nomisma Healthcare

4 Novo Excipients

2 Pharmatrans-Sanaq

7 Pluviaendo

3 Prachin Chemical

1 Qualicaps

19 Roquette

16 Seppic

CREAM;TOPICAL - 2.5%;2.5% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons